RECBIO-B (02179) announced that the company has recently received a filing notice from the China Securities Regulatory Commission (CSRC) dated January 13, 2026, regarding its H-share full circulation plan. According to the filing notice, the company has completed the filing with the CSRC for the conversion of a total of 142 million non-traded shares held by 28 shareholders into H-shares. This filing notice is valid for 12 months starting from January 13, 2026. The company will apply to The Stock Exchange of Hong Kong Limited for the approval to list and trade the corresponding H-shares.